Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High-Throughput Transcriptomic Analysis of Human Primary Hepatocyte Spheroids Exposed to Per- and Polyfluoroalkyl Substances as a Platform for Relative Potency Characterization
Andrea Rowan‐Carroll, Anthony Reardon, Karen Leingartner, et al.
Toxicological Sciences (2021) Vol. 181, Iss. 2, pp. 199-214
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Exposure to a mixture of legacy, alternative, and replacement per- and polyfluoroalkyl substances (PFAS) results in sex-dependent modulation of cholesterol metabolism and liver injury
Katherine Roth, Zhao Yang, Manisha Agarwal, et al.
Environment International (2021) Vol. 157, pp. 106843-106843
Open Access | Times Cited: 205
Perfluoroalkyl/Polyfluoroalkyl Substances: Links to Cardiovascular Disease Risk
Jennifer J. Schlezinger, Noyan Gokce
Circulation Research (2024) Vol. 134, Iss. 9, pp. 1136-1159
Open Access | Times Cited: 25
Adverse Effects of Perfluorooctane Sulfonate on the Liver and Relevant Mechanisms
Pingwei Wang, Dongge Liu, Shuqi Yan, et al.
Toxics (2022) Vol. 10, Iss. 5, pp. 265-265
Open Access | Times Cited: 41
From vision toward best practices: Evaluating in vitro transcriptomic points of departure for application in risk assessment using a uniform workflow
Anthony Reardon, Reza Farmahin, Andrew Williams, et al.
Frontiers in Toxicology (2023) Vol. 5
Open Access | Times Cited: 36
Understanding PFAS toxicity through cell culture metabolomics: Current applications and future perspectives
Thao V. Nguyen, Phan Nguyen Trang, Anupama Kumar
Environment International (2024) Vol. 186, pp. 108620-108620
Open Access | Times Cited: 13
Effects of PFAS on human liver transporters: implications for health outcomes
Ena Vujic, Stephen Ferguson, Kim L. R. Brouwer
Toxicological Sciences (2024) Vol. 200, Iss. 2, pp. 213-227
Open Access | Times Cited: 12
Progress in toxicogenomics to protect human health
Matthew J. Meier, Joshua Harrill, Kamin J. Johnson, et al.
Nature Reviews Genetics (2024)
Closed Access | Times Cited: 10
Potency Ranking of Per- and Polyfluoroalkyl Substances Using High-Throughput Transcriptomic Analysis of Human Liver Spheroids
Anthony Reardon, Andrea Rowan‐Carroll, Stephen Ferguson, et al.
Toxicological Sciences (2021) Vol. 184, Iss. 1, pp. 154-169
Open Access | Times Cited: 47
Integration of Toxicogenomics and Physiologically Based Pharmacokinetic Modeling in Human Health Risk Assessment of Perfluorooctane Sulfonate
Qiran Chen, Wei-Chun Chou, Zhoumeng Lin
Environmental Science & Technology (2022) Vol. 56, Iss. 6, pp. 3623-3633
Open Access | Times Cited: 33
Per- and polyfluoroalkyl substances (PFAS) in mixtures show additive effects on transcriptomic points of departure in human liver spheroids
Gregory C. Addicks, Andrea Rowan‐Carroll, Anthony Reardon, et al.
Toxicological Sciences (2023) Vol. 194, Iss. 1, pp. 38-52
Open Access | Times Cited: 22
Determination of in vitro hepatotoxic potencies of a series of perfluoroalkyl substances (PFASs) based on gene expression changes in HepaRG liver cells
Jochem Louisse, Styliani Fragki, Deborah Rijkers, et al.
Archives of Toxicology (2023) Vol. 97, Iss. 4, pp. 1113-1131
Open Access | Times Cited: 17
Innovation in regulatory approaches for endocrine disrupting chemicals: The journey to risk assessment modernization in Canada
Tara S. Barton‐Maclaren, Michael G. Wade, Niladri Basu, et al.
Environmental Research (2021) Vol. 204, pp. 112225-112225
Open Access | Times Cited: 34
Predicting the effects of per- and polyfluoroalkyl substance mixtures on peroxisome proliferator-activated receptor alpha activity in vitro
Greylin H. Nielsen, Wendy Heiger‐Bernays, Jennifer J. Schlezinger, et al.
Toxicology (2021) Vol. 465, pp. 153024-153024
Open Access | Times Cited: 33
Exploring the effects of experimental parameters and data modeling approaches on in vitro transcriptomic point-of-departure estimates
Joshua Harrill, Logan J. Everett, Derik E. Haggard, et al.
Toxicology (2023) Vol. 501, pp. 153694-153694
Closed Access | Times Cited: 14
HNF4A as a potential target of PFOA and PFOS leading to hepatic steatosis: Integrated molecular docking, molecular dynamic and transcriptomic analyses
Rui Li, Zijing Zhang, Yuxin Xuan, et al.
Chemico-Biological Interactions (2024) Vol. 390, pp. 110867-110867
Closed Access | Times Cited: 6
Mixtures of legacy and replacement perfluorosulphonic acids (PFSAs) demonstrate ratio-, concentration- and endpoint-dependent synergistic interactions in vitro
Hannah Mahoney, Francisco da Silva, Markus Brinkmann, et al.
Chemosphere (2024) Vol. 361, pp. 142446-142446
Open Access | Times Cited: 5
Comparison on the mechanism and potency of hepatotoxicity among hemp extract and its four major constituent cannabinoids
Xiugong Gao, Kayla Campasino, Miranda R. Yourick, et al.
Toxicology (2024) Vol. 506, pp. 153885-153885
Open Access | Times Cited: 5
Consensus on the key characteristics of metabolism disruptors
Michele A. La Merrill, Martyn T. Smith, Cliona M. McHale, et al.
Nature Reviews Endocrinology (2024)
Open Access | Times Cited: 5
In vitrotranscriptomic analyses reveal pathway perturbations, estrogenic activities, and potencies of data-poor BPA alternative chemicals
Geronimo Matteo, Karen Leingartner, Andrea Rowan‐Carroll, et al.
Toxicological Sciences (2022) Vol. 191, Iss. 2, pp. 266-275
Open Access | Times Cited: 22
Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes
Han‐Hsuan D. Tsai, Lucie C. Ford, Zunwei Chen, et al.
ALTEX (2024)
Open Access | Times Cited: 4
Empirical Characterization of False Discovery Rates of Differentially Expressed Genes and Transcriptomic Benchmark Concentrations in Zebrafish Embryos
Hyojin Lee, John D. H. Stead, Andrew Williams, et al.
Environmental Science & Technology (2024) Vol. 58, Iss. 14, pp. 6128-6137
Closed Access | Times Cited: 4
Canadian Regulatory Perspective on Next Generation Risk Assessments for Pest Control Products and Industrial Chemicals
Yadvinder Bhuller, Deborah Ramsingh, Marc A. Beal, et al.
Frontiers in Toxicology (2021) Vol. 3
Open Access | Times Cited: 26
Characterizing Variability and Uncertainty Associated with Transcriptomic Dose–Response Modeling
Jessica Ewald, Niladri Basu, Doug Crump, et al.
Environmental Science & Technology (2022) Vol. 56, Iss. 22, pp. 15960-15968
Closed Access | Times Cited: 18
GenX induces fibroinflammatory gene expression in primary human hepatocytes
Dakota R. Robarts, Kaitlyn K. Venneman, Sumedha Gunewardena, et al.
Toxicology (2022) Vol. 477, pp. 153259-153259
Open Access | Times Cited: 17
Using transcriptomics, proteomics and phosphoproteomics as new approach methodology (NAM) to define biological responses for chemical safety assessment
Yuan Li, Zhenpeng Zhang, Songhao Jiang, et al.
Chemosphere (2022) Vol. 313, pp. 137359-137359
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top